DNA X, Inc.

US$2.13As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:SONMFinancials
Country USA
PE (Fwd) •••
TSR 7Y CAGR (71.72%)
Div yield —
ROE —
Capital Markets
Beta (5Y) 1.82
PE TTM —
TSR TTM (81.65%)
Mkt cap US$3.170M
ROIC (275.50%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$2.34
9.72%
(70.24%)
Hold 7|11|12|6|8
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.04
0.05
0.05
0.05
18.80%
30.59%
33.29%
16.51%
Revenue$M
0.192
0.193
0.189
0.192
19.26%
15.16%
7.17%
4.49%
Peers (US$3.170M)
Cap (US$)
PE
9.888M
—
0.946M
—
3.248M
0.696x
Capital
TTM
5Y
10Y
Leveragex
1.367
1.982
1.416
EBIT/Intx
2.603
0.049
0.050
Own earn%
15.12
(59.95)
(62.22)
Sh yield%
33.09
39.13
37.89
Owners
Insiders/Inst%
0.97
73.75
Short interest%
4.17
SBC / revenue%
1.13
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
16
Op margin range%
13–19
$1 testx
—
Incr. ROIC%
7